Immunic, Inc. (IMUX) DCF Valuation

Immunic, Inc. (IMUX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Immunic, Inc. (IMUX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Immunic, Inc. (IMUX) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how different changes affect Immunic's valuation – all within one comprehensive Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -37.0 -48.9 -92.9 -120.3 -99.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .0 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -37.0 -49.0 -92.9 -120.4 -99.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 29.4 127.5 86.9 116.4 46.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories -.4 3.4 -2.2 -2.7 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.4 3.7 3.7 4.3 5.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -.1 -.1 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -36.9 -48.9 -92.8 -154.3 -99.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -34.1 -51.6 -87.2 -153.3 -101.3 -5.1 .0 .0 .0 .0
WACC, % 13.09 13.09 13.09 13.09 13.09 13.09 13.09 13.09 13.09 13.09
PV UFCF
SUM PV UFCF -4.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -5
Net Debt -45
Equity Value 41
Diluted Shares Outstanding, MM 44
Equity Value Per Share 0.92

What You Will Get

  • Real IMUX Financial Data: Pre-filled with Immunic, Inc.'s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Immunic, Inc.'s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Trial Parameters: Adjust essential inputs such as patient enrollment rates, treatment efficacy, and trial duration.
  • Real-Time Data Analysis: Provides instant insights on trial results, statistical significance, and other key metrics.
  • Industry-Leading Precision: Incorporates Immunic’s proprietary research for accurate predictive modeling.
  • Streamlined Scenario Testing: Easily evaluate various hypotheses and assess their potential impacts.
  • Efficiency Booster: Avoid the complexities of developing intricate clinical trial models from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Immunic, Inc.'s (IMUX) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Immunic, Inc.'s (IMUX) intrinsic value.
  • Step 5: Use the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator for Immunic, Inc. (IMUX)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Immunic, Inc. (IMUX).
  • Flexible Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
  • In-Depth Analysis: Automatically computes Immunic, Inc.'s (IMUX) intrinsic value and Net Present Value.
  • Preloaded Information: Access to historical and projected data for reliable analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and consultants focusing on Immunic, Inc. (IMUX).

Who Should Use This Product?

  • Investors: Assess Immunic, Inc.'s (IMUX) market potential before making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methods and evaluate financial forecasts for Immunic, Inc. (IMUX).
  • Startup Founders: Understand the valuation strategies of established biotech companies like Immunic, Inc. (IMUX).
  • Consultants: Create comprehensive valuation reports for clients interested in Immunic, Inc. (IMUX).
  • Students and Educators: Utilize real-time data to teach and practice valuation methodologies related to Immunic, Inc. (IMUX).

What the Template Contains

  • Preloaded IMUX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.